On 24 February, Advanced Micro Devices, Inc. (NASDAQ:AMD) is teaming up with game engine developer Oxide Games and publisher Stardock. Essentially, RTS games have been good at depicting small-scale battles. The goal of Ashes of the Singularity is to depict real-time wars. Thousands or even tens of thousands of 3D objects could appear on screen in such a game.
Advanced Micro Devices, Inc. (NASDAQ:AMD) belongs to Technology sector. Its net profit margin is -16.50% and weekly performance is 21.18%. On last trading day company shares ended up at $2.46. Advanced Micro Devices, Inc. (NASDAQ:AMD) distance from 50-day simple moving average (SMA50) is 2.42%.
On 26 February, The Dow Chemical Company (NYSE:DOW) agreed to pay $835 million to settle a decade-long lawsuit on price fixing, saying it had less chance of winning its petition at the Supreme Court after the death of Justice Antonin Scalia.
The Dow Chemical Company (NYSE:DOW) shares decreased -0.04% in last trading session and ended the day at $49.60. DOW Gross Margin is 22.40% and its return on assets is 10.60%. The Dow Chemical Company (NYSE:DOW) quarterly performance is -6.33%.
Plug Power Inc. (NASDAQ:PLUG) confirms it will release the Company’s 2015 fourth quarter and year end results on March 10, 2016.
On 03 March, Plug Power Inc. (NASDAQ:PLUG) shares increased 4.23% and was closed at $2.22. PLUG EPS growth in last 5 year was 29.20%. Plug Power Inc. (NASDAQ:PLUG) year to date (YTD) performance is 5.21%.
Brokerage firm Macquarie Maintains its rating on Hub Group Inc. (NASDAQ:HUBG). In a research note issued to the investors, the brokerage major Lowers a price-target of $36.00 per share. The shares have been rated Neutral.
Hub Group Inc. (NASDAQ:HUBG) ended the last trading day at $37.77. Company weekly volatility is calculated as 2.43% and price to cash ratio as 6.60. Hub Group Inc. (NASDAQ:HUBG) showed a weekly performance of 3.17%.
MiMedx Group, Inc. (NASDAQ:MDXG) supports the decision by the Food and Drug Administration (“FDA”) to postpone the April 13, 2016 hearing regarding the Draft Guidance for Human Cells, Tissues, and Cellular and Tissue-Based Products (“HCT/Ps”) in order to accommodate the significant interest and response to be heard on this matter. The Company stated that the FDA’s decision benefits patients, physicians, the industry and the FDA.
MiMedx Group, Inc. (NASDAQ:MDXG) shares moved down -0.79% in last trading session and ended the day at $8.84. MDXG Gross Margin is 89.20% and its return on assets is 17.50%. MiMedx Group, Inc. (NASDAQ:MDXG) quarterly performance is -1.01%.